-
1
-
-
0020621665
-
Malignant lymphoma of mucosa-associated lymphoid tissue. A distinctive type of B-cell lymphoma
-
Isaacson P, Wright DH. Malignant lymphoma of mucosa-associated lymphoid tissue. A distinctive type of B-cell lymphoma. Cancer 1983;52:1410-6.
-
(1983)
Cancer
, vol.52
, pp. 1410-1416
-
-
Isaacson, P.1
Wright, D.H.2
-
2
-
-
0001916934
-
Mucosa associated lymphoid tissue (MALT) and the MALT-lymphoma concept
-
Isaacson PG, Norton AJ, editors. Edinburgh (U.K.), London (U.K.), Madrid (Spain), Melbourne (Australia), New York (NY), and Tokyo (Japan): Churchill-Livingstone
-
Isaacson PG, Norton AJ. Mucosa associated lymphoid tissue (MALT) and the MALT-lymphoma concept. In: Isaacson PG, Norton AJ, editors. Extranodal lymphomas. Edinburgh (U.K.), London (U.K.), Madrid (Spain), Melbourne (Australia), New York (NY), and Tokyo (Japan): Churchill-Livingstone; 1994. p. 5-14.
-
(1994)
Extranodal Lymphomas
, pp. 5-14
-
-
Isaacson, P.G.1
Norton, A.J.2
-
3
-
-
0030948331
-
Mucosa-associated lymphoid tissue gastrointestinal and nongastrointestinal lymphoma behavior: Analysis of 108 patients
-
Thieblemont C, Bastion Y, Berger F, Rieux C, Salles G, Dumontet C, et al. Mucosa-associated lymphoid tissue gastrointestinal and nongastrointestinal lymphoma behavior: analysis of 108 patients. J Clin Oncol 1997; 15:1624-30.
-
(1997)
J Clin Oncol
, vol.15
, pp. 1624-1630
-
-
Thieblemont, C.1
Bastion, Y.2
Berger, F.3
Rieux, C.4
Salles, G.5
Dumontet, C.6
-
4
-
-
0028264524
-
Report on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma
-
Rohatiner A, d'Amore F, Coiffier B, Crowther D, Gospodarowicz M, Isaacson P, et al. Report on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma. Ann Oncol 1994;5:397-400.
-
(1994)
Ann Oncol
, vol.5
, pp. 397-400
-
-
Rohatiner, A.1
D'Amore, F.2
Coiffier, B.3
Crowther, D.4
Gospodarowicz, M.5
Isaacson, P.6
-
5
-
-
0029020938
-
Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of helicobacter pylori infection. MALT lymphoma study group
-
Bayerdorffer E, Neubauer A, Rudolph B, Thiede C, Lehn N, Eidt S, et al. Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. MALT Lymphoma Study Group. Lancet 1995;345: 1591-4.
-
(1995)
Lancet
, vol.345
, pp. 1591-1594
-
-
Bayerdorffer, E.1
Neubauer, A.2
Rudolph, B.3
Thiede, C.4
Lehn, N.5
Eidt, S.6
-
6
-
-
0027756152
-
The clinical spectrum and treatment of primary non-Hodgkin's lymphoma of the stomach
-
Taal BG, Burgers JM, van Heerde P, Hart AA, Somers R. The clinical spectrum and treatment of primary non-Hodgkin's lymphoma of the stomach. Ann Oncol 1993 ;4: 839-46.
-
(1993)
Ann Oncol
, vol.4
, pp. 839-846
-
-
Taal, B.G.1
Burgers, J.M.2
Van Heerde, P.3
Hart, A.A.4
Somers, R.5
-
7
-
-
0031005758
-
Endoscopic ultrasound in the evaluation of gastric small lymphocytic mucosa-associated lymphoid tumors
-
Pavlick AC, Gerdes H, Portlock CS. Endoscopic ultrasound in the evaluation of gastric small lymphocytic mucosa-associated lymphoid tumors. J Clin Oncol 1997;15: 1761-6.
-
(1997)
J Clin Oncol
, vol.15
, pp. 1761-1766
-
-
Pavlick, A.C.1
Gerdes, H.2
Portlock, C.S.3
-
8
-
-
0029166909
-
Evaluation of somatostatin analog in the treatment of lymphoproliferative disorders: Results of a phase II North Central cancer treatment group trial
-
Witzig TE, Letendre L, Gerstner J, Schroeder G, Mailliard JA, Colon-Otero G, et al. Evaluation of somatostatin analog in the treatment of lymphoproliferative disorders: results of a phase II North Central Cancer Treatment Group trial. J Clin Oncol 1995; 13: 2012-5.
-
(1995)
J Clin Oncol
, vol.13
, pp. 2012-2015
-
-
Witzig, T.E.1
Letendre, L.2
Gerstner, J.3
Schroeder, G.4
Mailliard, J.A.5
Colon-Otero, G.6
-
10
-
-
0030163039
-
Indium-111-pentetreotide uptake in endocrine tumors and lymphoma
-
Leners N, Jamar F, Fiasse R, Ferrant A, Pauwels S. Indium-111-pentetreotide uptake in endocrine tumors and lymphoma. J Nucl Med 1996;37:916-22.
-
(1996)
J Nucl Med
, vol.37
, pp. 916-922
-
-
Leners, N.1
Jamar, F.2
Fiasse, R.3
Ferrant, A.4
Pauwels, S.5
-
13
-
-
0032483743
-
Expression of human somatostatin receptor subtype 3 in pancreatic cancer in vitro and in vivo
-
Raderer M, Pangerl T, Leimer M, Valencak J, Kurtaran A, Hamilton G, et al. Expression of human somatostatin receptor subtype 3 in pancreatic cancer in vitro and in vivo. J Natl Cancer Inst 1998;90:1666-8.
-
(1998)
J Natl Cancer Inst
, vol.90
, pp. 1666-1668
-
-
Raderer, M.1
Pangerl, T.2
Leimer, M.3
Valencak, J.4
Kurtaran, A.5
Hamilton, G.6
-
14
-
-
0028929754
-
Inhibition of cell proliferation by the somatostatin analogue RC-160 is mediated by somatostatin receptor subtypes SSTR2 and SSTR 5 through different mechanisms
-
Buscail L, Esteve JP, Saint-Laurent N, Bertrand V, Reisine T, O'Carroll AM, et al. Inhibition of cell proliferation by the somatostatin analogue RC-160 is mediated by somatostatin receptor subtypes SSTR2 and SSTR 5 through different mechanisms. Proc Natl Acad Sci US A 1995;92:1580-4.
-
(1995)
Proc Natl Acad Sci USA
, vol.92
, pp. 1580-1584
-
-
Buscail, L.1
Esteve, J.P.2
Saint-Laurent, N.3
Bertrand, V.4
Reisine, T.5
O'Carroll, A.M.6
|